News
Jazz Pharmaceuticals to Participate in Upcoming November Investor Conferences
DUBLIN, Nov. 1, 2023 /PRNewswire/ — Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that Company management will participate in the following upcoming investor conferences:
Jefferies London Healthcare Conference on Tuesday, November 14, 2023
- Fireside chat at 4:30 a.m. PT / 7:30 a.m. ET / 12:30 p.m. GMT
6th Annual Evercore ISI HealthCONx Conference on Tuesday, November 28, 2023
- Fireside chat at 7:25 a.m. PT / 10:25 a.m. ET / 3:25 p.m. GMT
2023 BofA Leveraged Finance Conference on Wednesday, November 29, 2023
- Fireside chat at 7:10 a.m. PT / 10:10 a.m. ET / 3:10 p.m. GMT
Audio webcasts of the presentations will be available via the Investors section of the Jazz Pharmaceuticals website at https://investor.jazzpharma.com/investors/events-presentations. A replay of the webcasts will be archived on the website for 30 days.
About Jazz Pharmaceuticals
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is a global biopharmaceutical company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with serious diseases – often with limited or no therapeutic options. We have a diverse portfolio of marketed medicines and novel product candidates, from early- to late-stage development, in neuroscience and oncology. Within these therapeutic areas, we are identifying new options for patients by actively exploring small molecules and biologics, and through innovative delivery technologies and cannabinoid science. Jazz is headquartered in Dublin, Ireland and has employees around the globe, serving patients in nearly 75 countries. Please visit www.jazzpharmaceuticals.com for more information.
Contacts:
Investors:
Andrea N. Flynn, Ph.D.
Vice President, Head, Investor Relations
Jazz Pharmaceuticals plc
[email protected]
Ireland +353 1 634 3211
U.S. +1 650 496 2717
Media:
Kristin Bhavnani
Head of Global Corporate Communications
Jazz Pharmaceuticals plc
[email protected]
Ireland +353 1 637 2141
U.S. +1 215 867 4948
SOURCE Jazz Pharmaceuticals plc
-
Health1 year ago
Alan Thicke’s Intriguing Contribution To Juvenile Diabetes, Because His Legacy Lives On
-
Health1 year ago
Prevention And Treatment Of Opportunistic Infections In HIV
-
Health1 year ago
RSV Experimental Vaccine For Children- Risks And Consequences
-
Health1 year ago
Combat Stress: Effective Strategies And Resources For Managing Your Stress!
-
Health1 year ago
Reasons Why Your Pet Is The Perfect Workout Partner!
-
News1 year ago
Vladimir Putin In ‘Incredibly Difficult Position’ In Ukraine War: Joe Biden Says
-
Partner Content9 months ago
TRB Black Check Reviews – Is It A Check Worth Buying In 2023?
-
Trending11 months ago
Belle Delphine: All About The Bathwater Gamer Girl!